These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28685094)

  • 41. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
    Fuchs N; Bielack SS; Epler D; Bieling P; Delling G; Körholz D; Graf N; Heise U; Jürgens H; Kotz R; Salzer-Kuntschik M; Weinel P; Werner M; Winkler K
    Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.
    Bajpai J; Chandrasekharan A; Simha V; Talreja V; Karpe A; Pandey N; Singh A; Rekhi B; Vora T; Ghosh J; Banavali S; Gupta S
    J Glob Oncol; 2018 Sep; 4():1-10. PubMed ID: 30241240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus.
    Gupta GR; Yasko AW; Lewis VO; Cannon CP; Raymond AK; Patel S; Lin PP
    Cancer; 2009 Aug; 115(16):3767-73. PubMed ID: 19517468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-grade metachronous osteosarcoma. A case report over a 23-year period.
    Kalbermatten DF; Windisch W; Siebenrock KA
    Acta Orthop Belg; 2000 Dec; 66(5):507-13. PubMed ID: 11196378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
    Zhang C; Hu J; Zhu K; Cai T; Ma X
    Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Marginal excision for osteosarcoma with caffeine assisted chemotherapy.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Yamamoto N
    Clin Orthop Relat Res; 1999 Jan; (358):27-35. PubMed ID: 9973973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicin.
    Futani H; Fukunaga S; Tsukamoto Y; Terada N; Ono J; Okamoto N; Otsuka Y; Tanizawa T; Tomatsuri M; Yoshiya S
    Anticancer Res; 2012 Mar; 32(3):965-71. PubMed ID: 22399618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
    Schulz A; Fischer HP; Breithaupt H; Pralle H
    Onkologie; 1983 Dec; 6(6):296-304. PubMed ID: 6366675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neoadjuvant treatment in osteosarcomas].
    Kalifa C; Brugières L; Le Deley MC
    Bull Cancer; 2006 Nov; 93(11):1115-20. PubMed ID: 17145581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.
    Basaran M; Bavbek ES; Saglam S; Eralp L; Sakar B; Atalar AC; Bilgic B; Ozger H; Onat H
    Oncology; 2007; 72(3-4):255-60. PubMed ID: 18185020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
    Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
    Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteosarcoma with atypical location in an elderly female patient.
    Ogata DC; Moreira RS; Gomes AR; Pereira E; Sezerino DO; Hirano MB
    Autops Case Rep; 2011; 1(4):45-49. PubMed ID: 31528552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of large osteosarcoma in children: new approach.
    Kobys VL; Konovalenko VF; Repinа NV; Golovko TS; Gulak LO; Tarasova TO; Zaharycheva EV; Matyushok OF
    Exp Oncol; 2013 Jun; 35(2):105-8. PubMed ID: 23828385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
    Bacci G; Gherlinzoni F; Picci P; Van Horn JR; Jaffe N; Guerra A; Ruggieri P; Biagini R; Capanna R; Toni A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1337-45. PubMed ID: 3493903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neoadjuvant chemotherapy for osteosarcoma].
    Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteosarcoma around the knee treated with neoadjuvant chemotherapy and a custom-designed prosthesis.
    Bi W; Wang W; Han G; Jia J; Xu M
    Orthopedics; 2013 Apr; 36(4):e444-50. PubMed ID: 23590783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
    Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
    Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.